Skip to main content

NovoCure Ltd

NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001645113

No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in NovoCure Ltd as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
321
−40 vs. Q2 2021
Shares held
77.6M
−100.2K (−0.1%) vs. Q2 2021
Total value
$9.02B
−$8.21B (−47.7%) vs. Q2 2021
New holders
41
108 more added
Sold out
81
115 more reduced

4 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NVCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 321 institutions
Q1 2021: 329 institutionsQ2 2021: 365 institutionsQ3 2021: 321 institutionsQ4 2021: 313 institutionsQ1 2022: 309 institutionsQ2 2022: 318 institutionsQ3 2022: 305 institutionsQ4 2022: 306 institutionsQ1 2023: 298 institutionsQ2 2023: 269 institutionsQ3 2023: 229 institutionsQ4 2023: 220 institutionsQ1 2024: 238 institutionsQ2 2024: 237 institutionsQ3 2024: 225 institutionsQ4 2024: 239 institutionsQ1 2025: 228 institutionsQ2 2025: 243 institutionsQ3 2025: 245 institutionsQ4 2025: 239 institutionsQ1 2026: 224 institutionsQ2 2026: 218 institutions
Value heldQ3 2021: $9.02B
Q1 2021: $9.95BQ2 2021: $17.2BQ3 2021: $9.02BQ4 2021: $5.94BQ1 2022: $6.80BQ2 2022: $5.65BQ3 2022: $6.34BQ4 2022: $6.22BQ1 2023: $5.38BQ2 2023: $3.78BQ3 2023: $1.49BQ4 2023: $1.35BQ1 2024: $1.39BQ2 2024: $1.59BQ3 2024: $1.45BQ4 2024: $2.73BQ1 2025: $1.70BQ2 2025: $1.68BQ3 2025: $1.19BQ4 2025: $1.24BQ1 2026: $1.08BQ2 2026: $1.57B
Institutions holding NVCR and their total value by quarter
QuarterHoldersValue
Q2 2026218$1.57B
Q1 2026224$1.08B
Q4 2025239$1.24B
Q3 2025245$1.19B
Q2 2025243$1.68B
Q1 2025228$1.70B
Q4 2024239$2.73B
Q3 2024225$1.45B
Q2 2024237$1.59B
Q1 2024238$1.39B
Q4 2023220$1.35B
Q3 2023229$1.49B
Q2 2023269$3.78B
Q1 2023298$5.38B
Q4 2022306$6.22B
Q3 2022305$6.34B
Q2 2022318$5.65B
Q1 2022309$6.80B
Q4 2021313$5.94B
Q3 2021321$9.02B
Q2 2021365$17.2B
Q1 2021329$9.95B

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding NovoCure Ltd; share changes are against Q2 2021.

Institutions holding NVCR in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Sutton Wealth Advisors Inc.0$00.00%−5−100.0%Sold out
Wolff Wiese Magana LLC0$00.00%−5−100.0%Sold out
Pictet Asset Management Ltd––––Not filed
QS Investors, LLC––––Not filed
CWM, LLC––––Not filed
First Horizon Corp––––Not filed